Isotretinoin Gap (Isotretinoin)

Isotretinoin binds to retinoic acid receptors in the nucleus of skin cells, altering gene expression. This reduces keratinocyte proliferation, shrinks sebaceous glands, lowers sebum output, and provides anti‑inflammatory effects, collectively addressing the key factors that drive severe acne.

The dosage of Isotretinoin Gap is determined individually by the prescribing clinician based on the patient’s weight, severity of acne, and laboratory monitoring. No standard dose is provided here; the prescriber will set an appropriate regimen.

Isotretinoin Gap is classified as pregnancy category X because it is highly teratogenic. It must not be used by pregnant or nursing women, and effective contraception is required before, during, and after treatment to prevent fetal exposure.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with oral antibiotics, isotretinoin offers a disease‑modifying effect that can produce long‑term remission after a finite course, whereas antibiotics only suppress bacterial growth temporarily. Unlike hormonal therapies, isotretinoin works directly on sebaceous glands and keratinisation, making it suitable for both male and female patients with severe acne.

Store the product below 25 °C in its original container, protecting it from moisture and direct sunlight. Keep the packaging tightly closed and out of reach of children. Do not refrigerate or freeze the tablets, as temperature extremes can affect stability.

Isotretinoin Gap is taken orally, usually with a meal to improve absorption and reduce gastrointestinal irritation. The tablet should be swallowed whole with water; it is not intended for crushing, chewing, or dissolving.

The most critical risks include severe birth defects if exposure occurs during pregnancy, mood changes such as depression or suicidal thoughts, inflammatory bowel disease flare‑ups, and significant liver enzyme elevations. Patients should report any concerning symptoms to their healthcare provider promptly.

Individuals who are pregnant, planning to become pregnant, or breastfeeding should avoid isotretinoin. Patients with pre‑existing liver disease, uncontrolled hyperlipidaemia, or those taking high‑dose vitamin A supplements should also be excluded unless a specialist determines it is safe.